Kelsey A. Marciano

Evaluation of the pharmacokinetic interaction between letermovir and tacrolimus in allogeneic hematopoietic cell transplant recipients.

A. Cumpston, L. Veltri, K. Ross, 2022, Transplantation and cellular therapy.

Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse

C. McMahon, A. Kent, Amanda C. Winters, 2020, Bone Marrow Transplantation.

Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse

C. McMahon, A. Kent, D. Pollyea, 2023, Bone Marrow Transplantation.